(Q38115358)

29 August 2017

title

An update on current pharmacotherapy options for dyspepsia (English)

1 reference

29 August 2017

0 references

3

Nicholas Talley

1 reference

29 August 2017

Baharak Moshiree

1

1 reference

29 August 2017

Jose Barboza

series ordinal

2

1 reference

29 August 2017

language of work or name

English

0 references

publication date

19 June 2013

1 reference

Expert Opinion on Pharmacotherapy

29 August 2017

published in

1 reference

29 August 2017

volume

14

1 reference

29 August 2017

issue

13

1 reference

29 August 2017

page(s)

1737-1753

1 reference

Burden of gastrointestinal disease in the United States: 2012 update

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

Functional dyspepsia impairs quality of life in the adult population

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

Functional gastroduodenal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

Guidelines for the management of dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

Review article: current treatment options and management of functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

Heterogeneity of symptom pattern, psychosocial factors, and pathophysiological mechanisms in severe functional dyspepsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

Correlations among electrogastrogram, gastric dysmotility, and duodenal dysmotility in patients with functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

Helicobacter pylori eradication in functional dyspepsia: HEROES trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

American College of Gastroenterology guideline on the management of Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

Associations between gastric sensorimotor function, depression, somatization, and symptom-based subgroups in functional gastroduodenal disorders: are all symptoms equal?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

Recent insights on central processing and psychological processes in functional gastrointestinal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

AGA technical review: evaluation of dyspepsia. American Gastroenterological Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

Abnormal regional brain activity during rest and (anticipated) gastric distension in functional dyspepsia and the role of anxiety: a H(2)(15)O-PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

G-protein beta 3 subunit 825 CC genotype is associated with unexplained (functional) dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

Clinical and pathophysiological characteristics of acute-onset functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

Dyspepsia and irritable bowel syndrome after a Salmonella gastroenteritis outbreak: one-year follow-up cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

Intestinal immune activation in presumed post-infectious functional dyspepsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

Small bowel homing T cells are associated with symptoms and delayed gastric emptying in functional dyspepsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

Implications of eosinophilia in the normal duodenal biopsy - an association with allergy and functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

Meta-analysis: yield of diagnostic tests for coeliac disease in dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

Non-ulcer dyspepsia and duodenal eosinophilia: an adult endoscopic population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

Asian consensus report on functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

Measurement of gastric accommodation: a reappraisal of conventional and emerging modalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

Predictors of the placebo response in functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

Prolonged recording of duodenal acid exposure in patients with functional dyspepsia and controls using a radiotelemetry pH monitoring system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

Randomized, double-blind, placebo-controlled crossover trial of famotidine in patients with functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

Lansoprazole in the treatment of functional dyspepsia: two double-blind, randomized, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

Esomeprazole 40 mg once a day in patients with functional dyspepsia: the randomized, placebo-controlled "ENTER" trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

Is it possible to predict treatment response to a proton pump inhibitor in functional dyspepsia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

Effect and cost-effectiveness of step-up versus step-down treatment with antacids, H2-receptor antagonists, and proton pump inhibitors in patients with new onset dyspepsia (DIAMOND study): a primary-care-based randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

Heartburn-dominant, uninvestigated dyspepsia: a comparison of 'PPI-start' and 'H2-RA-start' management strategies in primary care--the CADET-HR Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

Effects of proton pump inhibitors on gastric emptying: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

Clopidogrel with or without omeprazole in coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

Proton pump inhibitors and histamine-2 receptor antagonists are associated with hip fractures among at-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

Acid-suppressive medication use and the risk for hospital-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

Meta-analysis of the effects of prokinetic agents in patients with functional dyspepsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

Efficacy of cisapride and domperidone in functional (nonulcer) dyspepsia: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

Itopride in functional dyspepsia: results of two phase III multicentre, randomised, double-blind, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

New-generation 5-HT4 receptor agonists: potential for treatment of gastrointestinal motility disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

Review article: clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

Oral domperidone in chronic postprandial dyspepsia. A double-blind placebo-controlled evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

Increased incidence of levodopa therapy following metoclopramide use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

Effect of chronic oral domperidone therapy on gastrointestinal symptoms and gastric emptying in patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

A placebo-controlled trial of acotiamide for meal-related symptoms of functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

Influence of erythromycin on gastric emptying and meal related symptoms in functional dyspepsia with delayed gastric emptying

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

Comparison of the effect of azithromycin versus erythromycin on antroduodenal pressure profiles of patients with chronic functional gastrointestinal pain and gastroparesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomised, double blind, placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: fast phase 3 repolarization prevents early afterdepolarizations and torsade de pointes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

Dyspepsia and health care seeking in a community: How important are psychological factors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

Antidepressants in the treatment of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

Influence of the selective serotonin re-uptake inhibitor, paroxetine, on gastric sensorimotor function in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

Selective effects of serotonergic psychoactive agents on gastrointestinal functions in health

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

Effect of the antidepressant venlafaxine in functional dyspepsia: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

Psychotropic agents in functional gastrointestinal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

Functional Dyspepsia Treatment Trial (FDTT): a double-blind, randomized, placebo-controlled trial of antidepressants in functional dyspepsia, evaluating symptoms, psychopathology, pathophysiology and pharmacogenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

Influence of buspirone on gastric sensorimotor function in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

Efficacy of the 5-HT1A agonist tandospirone citrate in improving symptoms of patients with functional dyspepsia: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

The multi-herbal drug STW 5 (Iberogast) has prosecretory action in the human intestine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

Meta-analysis: phytotherapy of functional dyspepsia with the herbal drug preparation STW 5 (Iberogast).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

A randomised clinical trial comparing the efficacy of a herbal preparation STW 5 with the prokinetic drug cisapride in patients with dysmotility type of functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

A treatment trial of acupuncture in IBS patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

Transcutaneous electroacupuncture improves dyspeptic symptoms and increases high frequency heart rate variability in patients with functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

Electroacupuncture accelerates solid gastric emptying and improves dyspeptic symptoms in patients with functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

Long-term improvement in functional dyspepsia using hypnotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

A pharmacological profile of the novel, peripherally-selective kappa-opioid receptor agonist, EMD 61753.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

Effect of asimadoline, a kappa opioid agonist, on pain induced by colonic distension in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

Asimadoline, a kappa-opioid agonist, and satiation in functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

Do we have an alternative for the Rome III gastroduodenal symptom-based subgroups in functional gastroduodenal disorders? A cluster analysis approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

Longitudinal and cross-sectional factors associated with long-term clinical course in functional dyspepsia: a 5-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

Human eosinophil major basic protein is an endogenous allosteric antagonist at the inhibitory muscarinic M2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

Increased prevalence of gastrointestinal symptoms in patients with allergic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

Duodenal ulcer treated with Helicobacter pylori eradication: seven-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.809063

Pharmacological interventions for non-ulcer dyspepsia

21 January 2018

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD001960.PUB3

Identifiers

DOI

10.1517/14656566.2013.809063

1 reference

29 August 2017

1 reference